ExScientia is an Artificial Intelligence (AI)-driven pharmatech company and scale-up, committed to discovering and designing the best possible medicines in the fastest and most effective manner, using AI. The company is the first company to progress AI-designed and ‘discovered’ small molecules into clinical settings, and has repeatedly demonstrated the ability of AI to transform how drugs are created. The idea is that designing better drugs, faster, will allow the best ideas of science to rapidly become the best medicines for patients. ExScientia has built dedicated AI systems that efficiently learn from the widest range of data and consistently re-apply enhanced knowledge through iterative product design.

Originally Homelync, a spin-out from the Bristol Robotics Laboratory, HomeLINK integrates and analyses sensor data to help landlords take a scalable and future-proofed approach to their IoT strategy. Through an analytics portal, a resident app and APIs that link (or homelink….) to existing IT systems, this Bristolian AI company provides landlords and their residents with actionable insights. The platform helps to reduce costs, improve customer services and solve some of society’s most pressing challenges including fuel poverty, health and social care, CO2 emissions and water waste. It also helps landlords reduce their tenant service costs and helps improve their tracking and customer service.